Amalgam Rx

Amalgam Rx is a US-based startup founded in 2016, which operates within the Biotechnology, Health Care, and Information Technology industries. The company's slogan, "Enabling better healthcare decisions. In the provider workflow. In patients’ everyday lives," encapsulates its mission to facilitate optimal decision-making for both healthcare providers and patients. Amalgam Rx achieves this through its suite of EHR Solutions and a modular SaMD platform, catering to leading life sciences companies, health plans, and provider organizations. Notably, its algorithms and applications currently support nearly 10 million patients across 4 continents, with a track record of aiding providers in over 50 million decisions. The most recent milestone for Amalgam Rx is the Series B investment it secured on 05 October 2023, with CVS Health as the investor. This investment attests to the confidence of a major industry player in Amalgam Rx's potential and innovative approach to improving healthcare through advanced technology and data-driven solutions. In conclusion, with its regulated digital products, EHR solutions, and a wealth of real-world evidence (10 billion RWE data points), Amalgam Rx demonstrates its commitment to engaging patients and providers, ultimately contributing to enhanced healthcare decision-making globally. For more details, interested parties can visit amalgamrx.com.